Related references
Note: Only part of the references are listed.First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers
Macarena Hernandez-Jimenez et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Defining a Target Population to Effectively Test a Neuroprotective Drug
Marta Olive-Gadea et al.
STROKE (2021)
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
Michael D. Hill et al.
LANCET (2020)
Targeting TLR4 with ApTOLL Improves Heart Function in Response to Coronary Ischemia Reperfusion in Pigs Undergoing Acute Myocardial Infarction
Rafael Ramirez-Carracedo et al.
BIOMOLECULES (2020)
Economic burden of stroke across Europe: A population-based cost analysis
Ramon Luengo-Fernandez et al.
EUROPEAN STROKE JOURNAL (2020)
TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models
Geronimo Fernandez et al.
MOLECULAR THERAPY (2018)
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
R. G. Nogueira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Reconsidering Neuroprotection in the Reperfusion Era
Sean I. Savitz et al.
STROKE (2017)
Combining Neuroprotection With Endovascular Treatment of Acute Stroke Is There Hope?
Michael Tymianski
STROKE (2017)
Translational Stroke Research Vision and Opportunities
Francesca Bosetti et al.
STROKE (2017)
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
T. G. Jovin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
M. Goyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
B. C. V. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
An-Wen Chan et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Neuroprotection for Stroke: Current Status and Future Perspectives
Jens Minnerup et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values
David Brea et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke
Javier R. Caso et al.
STROKE (2008)
Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke
Javier R. Caso et al.
CIRCULATION (2007)
Share Paper
